Oct 26, 2020On October 28, 2020, at 13:00, are being briefingOn October 28, 2020, at 13:00, are being briefing developers of the candidate for the SARS-CoV-2 vaccine. (COVID 19) The briefing will be...
Sep 23, 2020Speech at a scientific-practical conference with international participationSeptember 23, 2020 at the Scientific and Practical Conference with International Participation "Efficiency, Quality and Availability of...
Sep 18, 2020SCIENTIFIC AND PRODUCTION COMPANY "DIAPROF-MED" informsOn September 18, 2020, the company launched and operated a medical device for in vitro diagnostics - DIA®-SARS-CoV-2-Ag Enzyme-linked...
Sep 3, 2020RESULTS OF A COMPARATIVE STUDY OF SARS‐CoV‐2 IgG TESTsParallel testing of ninety‐two plasma samples of COVID‐19 convalescent donors, detected positive for IgG in the Abbott Architect...
May 5, 2020Notice of special information about the issuerInformation on the decision to pre-consent to major transactions
Apr 13, 2020We inform you about the expansion of the range of ELISASince April 13, 2020, the company has put into operation and operation a medical device for in vitro diagnostics - DIA®-SARS-CoV-2-NP-IgG...
Mar 30, 2020Annual general meeting of shareholdersPrivate Joint Stock Company Scientific-Production Company “DIAPROPH-MED” (USREOU code 24265186, location: Kyiv 03113, 68/1 Peremohy Ave.,...
Jan 15, 2020We offer new test kits for the diagnosis of Epstein-Barr virusWe offer new test kits for the diagnosis of Epstein-Barr virus: DIA®-EBV-VCA-IgG Enzyme immunoassay for the qualitative and...